TLIS (OTC)
TALIS BIOMEDICAL CORP
—
Change: —
Prev close: —
Company Information
- Exchange
- OTC Link
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- —
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-8.62 | $-7.52 | -1.1026 | -14.67% |
|
Mar 2023 (Q1)
|
$-9.90 | $-11.17 | +1.2690 | +11.36% |
|
Dec 2022 (Q4)
|
$-15.00 | $-10.48 | -4.5195 | -43.12% |
|
Sep 2022 (Q3)
|
$-14.70 | $-11.93 | -2.7660 | -23.18% |
Financial Statements
| Revenues | $408.00K |
| Benefits Costs and Expenses | $52.72M |
| Cost Of Revenue | $20.00K |
| Costs And Expenses | $55.53M |
| Gross Profit | $388.00K |
| Operating Expenses | $55.51M |
| Selling, General, and Administrative Expenses | $35.03M |
| Depreciation and Amortization | $774.00K |
| Research and Development | $20.48M |
| Operating Income/Loss | -$55.12M |
| Income/Loss From Continuing Operations After Tax | -$51.03M |
| Income/Loss From Continuing Operations Before Tax | -$53.04M |
| Net Income/Loss | -$51.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$51.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$51.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$28.02 |
| Diluted Earnings Per Share | -$28.02 |
| Basic Average Shares | 5,464,750 |
| Diluted Average Shares | 5,464,750 |
| Assets | $72.70M |
| Current Assets | $63.60M |
| Noncurrent Assets | $9.10M |
| Fixed Assets | $425.00K |
| Other Non-current Assets | $8.67M |
| Liabilities | $24.07M |
| Current Liabilities | $8.20M |
| Accounts Payable | $3.79M |
| Other Current Liabilities | $4.41M |
| Noncurrent Liabilities | $15.88M |
| Equity | $48.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $48.63M |
| Liabilities And Equity | $72.70M |
| Net Cash Flow From Operating Activities | -$40.26M |
| Net Cash Flow From Operating Activities, Continuing | -$40.26M |
| Net Cash Flow From Investing Activities | $137.00K |
| Net Cash Flow From Investing Activities, Continuing | $137.00K |
| Net Cash Flow From Financing Activities | $2.00K |
| Net Cash Flow From Financing Activities, Continuing | $2.00K |
| Net Cash Flow | -$40.12M |
| Net Cash Flow, Continuing | -$40.12M |
| Comprehensive Income/Loss | -$51.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$51.03M |
| Other Comprehensive Income/Loss | $0.00 |